Microsynth
Private Company
Funding information not available
Overview
Microsynth is a well-established, privately-held Swiss service provider in the genetics and genomics sector. For over three decades, it has built a reputation as a trusted European partner for custom oligonucleotide synthesis, DNA sequencing, and molecular biology contract research. Its business model is focused on providing essential research services and products to the life sciences community, positioning it as a stable, revenue-generating entity within the broader biotech ecosystem. The company maintains an active presence at European scientific conferences, indicating a focus on customer engagement and academic outreach.
Technology Platform
Platform for automated DNA/RNA oligonucleotide synthesis, DNA sequencing (likely Sanger and NGS), and molecular biology contract research services.
Opportunities
Risk Factors
Competitive Landscape
Microsynth competes in a fragmented but competitive market with large global players (e.g., Eurofins Genomics, Thermo Fisher Scientific, Azenta Life Sciences) and many regional/local service providers. Its competitive advantage lies in its long-established reputation, customer service focus, and deep integration within the European research community. Competition is based on price, turnaround time, quality, and range of services.